Defective Medical Device Claims in Ireland: A Patient’s Injury-Claim Guide (2026 Update)

What counts as a defective medical device under Irish law?

A medical device is defective when it does not provide the safety a person is entitled to expect, taking all circumstances into account. ¹ sets that test out in plain terms, and Irish courts have applied it to implants, prostheses, surgical instruments, contraceptive devices and active implants such as pacemakers.

The defect can sit in one of three places. A design defect exists when the product was unsafe before a single unit was made — the metal-on-metal hip is the textbook example, where wear was a feature of the design rather than an accident of manufacture. A manufacturing defect happens when a particular batch fails to match its own specification, often through contamination or material substitution. A warning or labelling defect arises when the instructions for use omit a known risk or fail to communicate it in a language the patient or surgeon can act on. Each route has the same legal standard, although the evidence is gathered differently.

One detail that catches many claimants off guard: a device can be legally defective even if it has not been recalled. A recall is a strong evidential signal, yet the test is the safety a reasonable person was entitled to expect, not the regulator’s administrative status.

How does a defective device claim differ from a medical negligence claim?

A defective device claim targets a fault in the product. A medical negligence claim targets a fault in the clinician’s care. The same injury can sometimes support both, although the two regimes have different defendants, different limitation periods and different procedural routes. We call the rubric for separating the two The Dual-Track Claim Test — four questions a solicitor asks early in the file.

The four questions in The Dual-Track Claim Test are these. Was the device on a recall or Field Safety Notice when it was implanted? Did the surgeon take a recognised consent route for that risk? Did anyone fail to act on a known regulator alert? And is revision surgery now needed because of the device, the operation, or both? When the answers split across product and clinician, both tracks are pleaded.

Unlike in England and Wales, where general personal injury claims have a three-year limit, the standard Irish personal injury limit is two years under the Civil Liability and Courts Act 2004 (Updated 2024) [3]. That two-year window applies to a clinical negligence track. The product track, governed by the 1991 Act, runs to three years. A claimant whose case sits on both tracks must respect the shorter clock for the negligence element.

A medical negligence claim against the surgeon or hospital follows separate evidential rules and requires an independent expert opinion before letters of claim issue.

Who can be held liable for a defective medical device in Ireland?

Liability runs first to the manufacturer of the device. Where the manufacturer is outside the European Union, the claim attaches to the EU importer or, failing that, the EU authorised representative the manufacturer must designate under the EU Medical Device Regulation 2017/745 (Updated 2025) [4]. The supplying hospital is rarely the right defendant for a pure product claim, although it can become a co-defendant if it knew of a recall and continued to use the device.

One development in EU case law that strengthens claimants’ positions: in Joined Cases C-503/13 and C-504/13 (Boston Scientific Medizintechnik), the Court of Justice of the European Union held that where a sample of a class of medical devices is shown to be defective, all devices in the same group can be presumed defective without each one needing to be individually tested. That principle is particularly significant in batch-failure claims such as pacemakers, ICDs and implantable cardioverter leads.

The State Claims Agency’s Indemnity Schemes (Updated 2024) [5] expressly exclude “claims for personal injury liability for defective products” from the Clinical Indemnity Scheme. In practice, that means defective-device claims run against the manufacturer’s product-liability insurer rather than against the State. A surgeon’s clinical conduct, by contrast, sits inside the scheme when it happens in an HSE or voluntary-hospital setting.

One distinction that matters at pleading stage: section 2 of the 1991 Act treats anyone who imports a product into the EU as a producer for liability purposes, and treats a supplier as the producer where the actual producer cannot be identified within a reasonable time. A hospital that imports a device directly, or that cannot identify its supplier on request, can find itself in the producer’s seat for that claim.

What time limits apply to a defective medical device claim?

You have three years from the date you knew, or should reasonably have known, that a defective device caused your injury, with a ten-year longstop from the date the product was first put into circulation. Section 7 of the ¹ is the source rule, and it operates differently from the general two-year personal injury limit in the ³.

What does “date of knowledge” actually mean in an implant case? Many patients live with mild discomfort for years and only connect it to the implant when a GP, an X-ray report or a recall letter joins the dots. The clock starts when those dots are joined — not at the date of surgery. Our note on date of knowledge walks through the legal test and what counts as evidence of when knowledge crystallised.

The ten-year longstop is harder. It cuts off claims where the product was first put into circulation more than ten years ago, even when knowledge only arrived recently. From 9 December 2026, that longstop extends up to 25 years for medically recognised injuries with a long latency, under the new directive discussed below.

Unlike in England and Wales, where defective product claims sit under the Consumer Protection Act 1987, Ireland operates the equivalent rules through the Liability for Defective Products Act 1991. The numbers are similar (three years, ten-year longstop) but the statute, the courts and the regulator are Irish.

What changes from 9 December 2026 — the Revised EU Product Liability Directive

From 9 December 2026, claims arising from medical devices placed on the market after that date will be governed by ², which Ireland must transpose by the same deadline. The 1991 Act continues to govern claims about products placed on the market before 9 December 2026, so most existing implants stay under the older regime. The two regimes will run in parallel for years.

The practical effect for patients is significant. Claimants who would have struggled to prove the technical mechanism of failure may benefit from the new presumptions. Patients with delayed-onset injuries from devices implanted just before the deadline may have a longer window to act. A patient with diagnosed PTSD after a serious recall, where the physical injury is modest, may have a clearer claim than they do today.

Because the trigger is the placed-on-market date and not the date of implantation, the two regimes will run side-by-side for many years.

↑ Back to top

Do you need to go to the Injuries Resolution Board first?

Whether you need Injuries Resolution Board (IRB) authorisation — formerly known as the Personal Injuries Assessment Board (PIAB) until 14 December 2023 — before issuing court proceedings against a device manufacturer is a settled but specific question. Section 3(d) of the Personal Injuries Assessment Board Act 2003 (Updated 2023) [7] exempts personal injuries claims arising out of the provision of a health service or medical or surgical procedure or treatment by the defendant. The question is whether an implant-defect claim against a manufacturer sits inside that exemption.

Two High Court authorities have answered this question. In Murphy v DePuy [2015] IEHC 153, Ms Justice Faherty held that a claim against a hip implant manufacturer did not fall within the section 3(d) exemption, because the claim arose out of the manufacture and supply of a defective product rather than out of medical treatment by the defendant. PIAB (now IRB) authorisation was therefore required. In the later case of Creedon v DePuy, Ms Justice O’Hanlon followed Murphy and reached the same conclusion on substantively similar facts. The practical position for a pure product claim against a manufacturer is therefore that IRB authorisation is required before issuing proceedings. Failure to obtain authorisation is a full defence and can statute-bar the claim. The section 3(d) exemption applies where the defendant is the surgeon, hospital or HSE (medical negligence track), not where the defendant is the device manufacturer.

What evidence do you need? The Implant Card Evidence Chain

Strong defective-device claims share a common evidence path. We call it The Implant Card Evidence Chain, a six-step protocol that takes the file from initial enquiry to a defendable letter of claim.

“The single biggest factor we see in the strength of an Irish defective-device file is whether the explanted device was retained at revision surgery. A patient who has the Implant Card, the operative note, the Field Safety Notice and the device itself is in a different position from one relying on records alone.”

Not every device must carry an Implant Card. Under the EU MDR, the obligation depends on the risk class of the device, which determines what evidence the patient is entitled to receive.

Class III is where most defective-device claims sit. The HPRA also classifies recalls themselves on a separate three-tier scale. Class I recalls are issued where the defect is reasonably likely to cause serious adverse health consequences or death. Class II recalls apply for temporary or medically reversible effects. Class III recalls are issued where injury is unlikely. Knowing which class your device’s recall sits in tells you how strong the evidential lift is on causation.

Recall vs Field Safety Notice (FSN)

A recall removes the device from the market. An FSN may include a recall, a correction, an instruction update, or a usage warning. All FSNs are evidence, although not all FSNs are recalls.

Implant Card vs operative note

The Implant Card lists the device, model, lot and UDI. The operative note is the surgeon’s record of the procedure. You usually need both for a claim.

Voluntary recall vs mandatory removal

A voluntary recall is initiated by the manufacturer. A mandatory removal is directed by the HPRA. Both are admissible, although the latter often shifts the evidential burden.

Defective device claim vs medical negligence claim

The product claim targets the manufacturer under strict liability with a 3-year limit. The negligence claim targets the clinician with the Dunne test and a 2-year limit. Both can be pleaded in a hybrid claim.

1. Locate the Implant Card. Under ⁴, every patient implanted in Ireland with a Class IIb implantable or Class III device certified under the MDR (which has applied since 26 May 2021) must be given a card listing the device name, model, lot number and Unique Device Identifier. Older devices certified under the previous Medical Device Directive remain in transitional use, so a patient implanted with MDD-certified stock may not have a card. If you cannot find one, request a duplicate or the equivalent device sticker from the implanting hospital.
2. Look up the UDI in EUDAMED. The EU’s public database (ec.europa.eu/tools/eudamed) returns the manufacturer details and the device’s registered safety information.
3. Search the HPRA Field Safety Notice register. The ⁸ publishes monthly summaries of Field Safety Notices affecting the Irish market and assessed 3,672 medical device vigilance reports in 2024. A match for your model is strong supporting evidence.
4. Fix the date of knowledge in writing. A GP letter, a referral, or a contemporaneous note that links your symptoms to the device anchors the three-year clock.
5. Identify the right defendant. If the manufacturer is outside the EU, find the EU importer or authorised representative listed in EUDAMED. They are the proper Irish defendant.
6. Preserve the device on revision. Ask your surgeon, in writing, to retain the explanted device for engineering analysis. Materials testing on a fractured or worn component often answers the causation question that medical records cannot.

Requesting your medical records early matters in either scenario. Hospital records can take 30 days or longer to produce, and gaps in chronology weaken the claim.

↑ Back to top

What most guides miss about defective device claims in Ireland

Four assumptions surface repeatedly in patient enquiries, and each one is wrong on the Irish facts.

• “The two-year personal injury limit applies.” It does not for the product claim. Section 7 of the Liability for Defective Products Act 1991 sets the limit at three years from date of knowledge. The two-year limit applies to the clinical-negligence track, where one is added to the file.
• “You need a recall to claim.” A recall is strong evidence but is not a precondition. Many devices fail without ever being formally recalled, and a HPRA Field Safety Notice short of a full recall is enough to anchor the claim.
• “The HSE pays the compensation.” Defective product claims are excluded from the State Claims Agency’s Clinical Indemnity Scheme. The manufacturer’s product liability insurer pays, not the State.
• “Class actions like the US are available.” Ireland has no general class action mechanism. The Representative Actions Act 2023 allows a qualified entity to bring representative actions for consumer rights, and multi-claimant device litigation more often runs through a court-supervised ADR scheme on the DePuy ASR model.

↑ Back to top

What if your situation is more complex than a standard implant case?

Beyond the typical hip-, knee- or mesh-revision file sit a number of more complex situations that the standard implant playbook does not cover. The next sections deal with quantum, brand-specific recall pathways, multi-claimant routes, the defences manufacturers commonly run, and the practical first steps if you think you may have a claim.

How is compensation calculated under the Personal Injuries Guidelines?

Compensation in Ireland is calculated using the Personal Injuries Guidelines (commenced 24 April 2021) [9], which replaced the Book of Quantum and set out general damages ranges by injury severity. Special damages cover quantifiable financial losses such as medical expenses, revision-surgery costs, loss of earnings and future care. The Guidelines were the subject of draft amendments published by the Judicial Council in December 2024 and submitted to the Minister for Justice on 31 January 2025, proposing a 16.7% inflation uplift. Following a Cabinet Sub-Group on Insurance Reform decision on 9 July 2025, the Minister announced he would not seek a resolution of approval. The draft was laid before the Oireachtas in September 2025 but no approval resolution was tabled, so the original 2021 figures remain the legally binding reference. The Judicial Council (Amendment) Bill 2026 is being progressed to clarify the future revision process.

General damages depend on injury severity, not on the brand of device. A severe hip injury with chronic pain and limited mobility sits in a different bracket from a fully resolved soft-tissue injury, and the Guidelines list the factors that move an award within a bracket: age, duration, treatment intensity, working capacity, psychological consequences and pre-existing degeneration. Awards vary case by case.

Our note on the three categories of damages covers the technical detail of how general, special and (rarely) aggravated damages combine.

How does Ireland compare with the UK and other EU countries?

Patients sometimes assume Irish defective-device rules track the UK position. They mostly do not. The Irish position has its own statute, its own time limits, its own pre-action body, and from 9 December 2026 will sit under a fresh EU directive that the UK is not implementing.

Element

Republic of Ireland

England & Wales (post-Brexit)

Governing statute

Liability for Defective Products Act 1991

Consumer Protection Act 1987

PI limitation

3 years from date of knowledge

3 years from date of knowledge

Longstop

10 years (rises to up to 25 years for latent injury from 9 Dec 2026 under the Revised PLD)

10 years (UK is not implementing the Revised PLD 2024/2853)

Pre-action body

IRB authorisation typically required for claims against manufacturers

CPR pre-action protocol, no equivalent statutory body

Fee model

Percentage-of-damages fees prohibited (LSRA 2015 s.149)

Damages-based agreements and CFAs are permitted

Regulator

HPRA, EU MDR 2017/745, EUDAMED

MHRA (divergent post-Brexit framework)

This comparison is for orientation only. A patient injured in Ireland brings their claim under Irish law regardless of where the manufacturer is based.

Common defective device situations in Ireland

The Irish caseload over the past fifteen years clusters around a handful of device families. Each is a candidate for its own dedicated claim guide.

• DePuy ASR hip and DePuy Attune knee: The DePuy ASR hip is the canonical Irish defective-device case. Around 3,300 ASR hips were implanted in Ireland across 16 public and 14 private hospitals before the 2010 worldwide recall, including at the Mater, Beaumont, Tallaght, St James’s, Cork University Hospital and Galway University Hospital. By early 2019, the Irish Times reported 1,112 sets of proceedings had been lodged with the High Court. A court-supervised alternative dispute resolution scheme was directed by Mr Justice Cross in 2015. Reported average settlements were around €100,000. On a per-capita basis, more DePuy ASR hips were implanted in Ireland than in any other jurisdiction. The DePuy Attune knee has generated a smaller but rising Irish caseload focused on tibial baseplate loosening.
• Other metal-on-metal hips: Stryker, Zimmer and Smith & Nephew systems have generated similar revision-surgery and metallosis claims internationally, with smaller Irish caseloads. Orthopaedic negligence overlaps where surgical positioning is also alleged to have failed.
• Transvaginal mesh and pelvic mesh: The HSE paused vaginal mesh procedures in 2018 after the Chief Medical Officer’s report. Around 3,000 mesh devices had been supplied in Ireland since the late 1990s. HSE patient information (Updated 2024) [10] sets out the current pause. Obstetrics and gynaecology negligence covers the consent-side overlap.
• Hernia mesh: Polypropylene hernia meshes have generated international litigation, and Irish claims tend to combine product defect with arguments about consent quality.
• Allergan textured breast implants: The 2019 worldwide BIOCELL recall, prompted by the rare lymphoma BIA-ALCL, had a particular Irish dimension because Allergan was Irish-domiciled at the time, with its corporate headquarters in Dublin. Allergan was acquired by AbbVie in 2020 and is now a wholly owned AbbVie subsidiary, although AbbVie maintains substantial Irish operations and the Irish-jurisdiction angle for service and discovery in BIA-ALCL claims remains relevant.
• Pacemakers and ICDs: Recalls of cardiac rhythm devices engage cardiology evidence as well as device-side failure-mode analysis.
• Spinal cord stimulators, cochlear implants, insulin pumps and contraceptive devices: Each has its own evidence path, although the Implant Card Evidence Chain applies in the same way.

Can you bring a class action for a defective device in Ireland?

Ireland does not have a general class action mechanism. What it has, since the Representative Actions for the Protection of the Collective Interests of Consumers Act 2023 (Updated 2024) [11], is a representative action procedure that allows a designated “qualified entity” to bring claims on behalf of consumers for breaches of EU consumer rights, including defective products. The first such application reached the High Court in May 2025. Most multi-claimant device litigation in Ireland still runs through the older test-case and ADR-scheme model, as it did with the DePuy ASR hip.

One distinction matters when the file is built: a manufacturer’s voluntary recall (a Field Safety Corrective Action initiated by the manufacturer and notified to the HPRA) and a mandatory removal directed by the HPRA carry different evidential weights. A voluntary recall is the manufacturer acknowledging a problem on its own analysis, while a mandatory removal records the regulator concluding the manufacturer’s response was insufficient. Both are admissible, although the latter often shifts the burden in practice.

What defences do manufacturers commonly raise?

Manufacturers and their insurers run four lines of defence regularly. The development risk defence in section 6(e) of the 1991 Act allows a manufacturer to escape liability if scientific and technical knowledge at the time of supply was not such that the defect could be discovered. It worked in the Irish narcolepsy-vaccine litigation, although it has been narrower in implant cases.

Misuse and contributory fault arise where the patient or surgeon is said to have used the device contrary to the instructions for use. Time bar is run hard in latent-injury cases, with manufacturers arguing that knowledge crystallised earlier than the claimant says. Causation challenges are the most common defence: the manufacturer accepts the recall but says the patient’s specific injury would have happened anyway, often citing pre-existing degeneration. Independent expert reports, contemporaneous imaging, and the explanted device itself carry the weight of the rebuttal.

What to do next if you think you may have a claim

If a recall letter has reached you or symptoms have brought you back to your GP, the practical next steps are short.

1. Locate your Implant Card or request a duplicate from the implanting hospital.
2. Save any HPRA Field Safety Notice and any letter from the manufacturer or hospital.
3. Photograph the device packaging if you still have it.
4. Note the date your symptoms began and the date you first connected them to the device.
5. Speak to a solicitor experienced in product liability and medical negligence before the three-year clock affects evidence preservation.

↑ Back to top

Frequently asked questions

Key terms used in defective medical device claims

The terms below appear repeatedly across HPRA notices, EU regulations and Irish case files. A short reference for each.

Defective product

Under section 5 of the Liability for Defective Products Act 1991, a product is defective when it does not provide the safety a person is entitled to expect, taking all circumstances into account.

Strict liability

Liability without proof of fault. Under the 1991 Act, a claimant proves defect, damage and causation, but does not have to prove the manufacturer was careless.

Date of knowledge

The date on which the claimant first knew, or could reasonably have known, that the device caused the injury. The three-year limitation clock starts from this date, not from the date of surgery.

Longstop

A hard time bar measured from when the product was first put into circulation. Ten years under the 1991 Act, and up to 25 years for latent personal injuries under the Revised PLD 2024/2853 from 9 December 2026.

Implant Card

A card the manufacturer must supply to every patient implanted with a Class IIb implantable or Class III device since 26 May 2021, under Article 18 of the EU Medical Device Regulation 2017/745. Lists the device name, model, lot number and Unique Device Identifier.

Unique Device Identifier (UDI)

A traceable code on the Implant Card and the device packaging that lets a solicitor cross-reference EUDAMED, HPRA Field Safety Notices and the manufacturer’s technical file.

EUDAMED

The European Database on Medical Devices. Public-facing modules let patients and lawyers verify device data, manufacturer details and EU representative for non-EU manufacturers.

Field Safety Notice (FSN) / Field Safety Corrective Action (FSCA)

Manufacturer-issued safety notices the HPRA publishes. An FSN can be a recall, a correction, a software update or a usage warning. A match for your device is strong supporting evidence.

HPRA

The Health Products Regulatory Authority. Ireland’s regulator for medicines and medical devices, which publishes Field Safety Notices and oversees device-related vigilance.

Clinical Indemnity Scheme (CIS)

The State Claims Agency’s scheme that covers clinical negligence claims against the HSE and voluntary hospitals. Defective product claims are excluded, which is why these claims run against the manufacturer’s product liability insurer rather than the State.

Revised PLD

Directive (EU) 2024/2853, the new EU Product Liability Directive. Replaces the 1985 Directive (and Ireland’s 1991 Act for products placed on the market from 9 December 2026 onwards).

↑ Back to top

Related guides on this site

If a defective medical device is part of a larger picture, these companion guides cover the connecting questions:

• Surgical errors and medical negligence in Ireland — for the negligence track when a recall was missed or a surgeon erred.
• Personal Injuries Guidelines explainer — for how a compensation bracket is selected.
• The Injuries Resolution Board process — for the procedural detail on IRB applications.
• How long does a personal injury claim take in Ireland? — for the realistic timeline.
• The three categories of damages — for general, special and aggravated damages.
• No-win-no-fee in medical and product cases — for how Section 150 letters and deferred fees work.
• Legal costs in medical claims — for outlay budgets and Calderbank offers.
• Who can make a personal injury claim — for capacity, minors and fatal-injury claimants.

References

All primary sources below were verified against their canonical publishers on 5 May 2026. Statutory references are to the Irish Statute Book consolidated text. EU references are to EUR-Lex. Case law is cited via courts.ie.

1. Liability for Defective Products Act 1991 — Irish Statute Book
2. Directive (EU) 2024/2853 of the European Parliament and of the Council on liability for defective products — EUR-Lex
3. Civil Liability and Courts Act 2004 — Irish Statute Book
4. Regulation (EU) 2017/745 on medical devices (MDR) — EUR-Lex
5. State Claims Agency Indemnity Scheme FAQ — stateclaims.ie
6. Courts Service of Ireland Judgments database — courts.ie
7. Personal Injuries Assessment Board Act 2003 — Irish Statute Book
8. HPRA Medical Device Safety Notices — Health Products Regulatory Authority
9. Personal Injuries Guidelines (April 2021) — Judicial Council of Ireland
10. Vaginal mesh implants — patient information — HSE
11. Representative Actions for the Protection of the Collective Interests of Consumers Act 2023 — Irish Statute Book
12. Joined Cases C-503/13 and C-504/13 Boston Scientific Medizintechnik (CJEU, 5 March 2015) — EUR-Lex
13. Legal Services Regulation Act 2015 — Irish Statute Book
14. EUDAMED — European Database on Medical Devices — European Commission